Researchers anxiously await a decision by US regulators on a controversial cancer therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
NRDD: Rethinking therapeutic cancer vaccines
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. A shot in the arm for cancer vaccines?. Nature 464, 1110–1111 (2010). https://doi.org/10.1038/4641110a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4641110a